Story:DCAT ’08 Opportunities for generics

DCAT ’08 Opportunities for generics

DCAT ’08 Opportunities for generics

Dave Harding of Thomson talks to Simon Robinson about the opportunities for generic drugs in the US as patents expire.

Please select a clip

13 Jun 08 15:10	ICIS radio: Chemical News Central: 16 June 2008
09 Jun 08 16:34	ICIS radio: Chemical News Central: 9 June 2008
09 Jun 08 13:41	ICIS radio Americas June 9, 2008
06 Jun 08 14:01	FECC '08: Dipol interview
03 Jun 08 16:41	ICIS radio: FECC ’08: Marc Fermont
30 May 08 21:05	ICIS radio Americas June 2, 2008
27 May 08 13:49	ICIS radio Americas May 26, 2008
23 May 08 15:44	ICIS radio: Chemical News Central: 23 May 2008
16 May 08 22:03	ICIS radio Americas May 19, 2008
16 May 08 16:05	ICIS radio: Chemical News Central: 19 May 2008
11 May 08 21:45	ICIS radio Americas May 12, 2008
09 May 08 15:58	ICIS Radio: Chemical News Central: 9 May
06 May 08 23:23	ICIS radio Americas May 5, 2008
02 May 08 15:17	ICIS radio Chemical News Central 5 May 2008
30 Apr 08 12:03	DCAT ’08 Sidney Taurel of Eli Lilly on innovation
30 Apr 08 12:02	DCAT ’08 overlapping business models
30 Apr 08 11:59	DCAT ’08 Opportunities for generics
30 Apr 08 11:58	DCAT ’08 How the market values pharma
30 Apr 08 11:57	DCAT ’08 Projected prescribing trends
30 Apr 08 11:56	DCAT ’08 Is pharma sponsored research biased?